David Parker, Ph.D., Boston Healthcare Associates

David Parker has spent the past 25 years in the healthcare industry, including 14 years of strategy consulting experience centered on the intersection of reimbursement, health economics, clinical science, and marketing strategy. He currently leads the Washington office of Boston Healthcare Associates and provides strategic advisory services to the firm’s biopharma, device, and diagnostics clients. His consulting encompasses all aspects of reimbursement and market strategy development with a particular focus on medical devices, molecular diagnostics, and personalized medicine. Preceding his appointment at Boston Healthcare, he was a senior consulting executive at Covance Market Access Services, where as a Vice President he led the Economic Strategies and Devices/Diagnostics practices. His work has resulted in numerous successful product launches, expanded market access, and favorable coverage and payment decisions by public and private payers alike.

Prior to Covance, Dr. Parker was president of a biomedical consulting firm. His consulting career was preceded by eleven years of increasingly-responsible product and marketing management, strategic planning, and business development roles at several biotechnology companies ranging from development-stage to Fortune 500. Early in his career, he conducted research in cell biology at Northwestern University Medical School.

Dr. Parker received a Ph.D. in Cell and Developmental Biology from the Massachusetts Institute of Technology, and an A.B. with high honors in Biochemistry from Princeton University.

Read Dr. Parker’s latest contributions to The Age of Personalized Medicine Blog

%d bloggers like this: